GlassScriptPhysician profile
Tyler J Lesko
NPI 1003548538
$2,694.01
in general payments reported to CMS, 2019-2025
17 companies · $873 in 2025
The $873 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $421 · 2023: $274 · 2024: $1,126 · 2025: $873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,273.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $991.87 | 2022-2025 | Xiidra, Miebo, Infuse |
| Alcon Vision LLC | $294.93 | 2022-2025 | Precision7, Total30, Eysuvis |
| Oyster Point Pharma, INC. | $264.33 | 2022-2024 | Tyrvaya |
| Coopervision INC. | $199.42 | 2024-2025 | Myday Contact Lens, Misight Contact Lens |
| Biotissue Holdings INC. | $190.54 | 2024 | |
| Abbvie INC. | $136.73 | 2022-2023 | |
| Tarsus Pharmaceuticals, INC. | $113.96 | 2025 | |
| Dompe US, INC. | $110.44 | 2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $79.92 | 2022-2023 | |
| Johnson & Johnson Vision Care, INC. | $68.07 | 2025 | |
| Sun Pharmaceutical Industries INC. | $61.61 | 2022-2025 | Cequa |
| Teva Pharmaceuticals USA, INC. | $50.69 | 2025 | Austedo Xr, Uzedy |
| Harrow Eye, LLC | $45.70 | 2025 | Vevye |
| Rxsight INC | $28.31 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Sight Sciences, INC. | $28.11 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.47 | 2024 | Tepezza |
| Eyevance Pharmaceuticals LLC | $13.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Lesko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.